{
  "docId": "019de072-1970-7036-9d15-9ffed6304914",
  "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 35,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "thesis_headline",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a flow-chart style diagram to segment the patient population and position the Lynparza + abiraterone combination.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/25",
  "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914",
  "deckJsonHref": "/decks/019de072-1970-7036-9d15-9ffed6304914.json",
  "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.61,
        "x": 0.07,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Patient segmentation flow chart for 1st-line mCRPC",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c09b792d-e218-4550-a081-475a7c9b8c53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.52,
        "w": 0.43,
        "x": 0.57,
        "y": 0
      },
      "kind": "image",
      "text": "Patient photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b5f43a0-fada-416d-8164-9fadf5d234b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.67,
        "y": 0.56
      },
      "kind": "paragraph",
      "text": "A clear option for NHA-naïve patients regardless of HRRm status. The first combination trial to demonstrate consistent clinical benefit in 1st-line mCRPC",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea982320-c295-40b9-b3da-aff0c8edda39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.03,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: AstraZeneca estimates. 1. Pending health authority authorisation. The PROpel trial data is not currently approved in any jurisdiction.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f8b13a9-e13b-4a3d-9ee8-f267cb2e107b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.48,
        "x": 0.03,
        "y": 0.08
      },
      "kind": "title",
      "text": "PROpel: a new treatment approach in 1st-line mCRPC",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "614fd95c-0cc4-4250-9154-623ecb002956",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Thesis archetype",
      "slug": "thesis-archetype",
      "agent": null,
      "layer": "slide",
      "matchId": "0c4e4648-b71f-43a5-80f4-f371a9b9f64a",
      "evidence": "paragraph/paragraph: A clear option for NHA-naïve patients regardless of HRRm status.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 23,
      "beatId": "7bf432cb-b1a5-4aae-a899-3cdafdfd475a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The deck presents the PROpel trial results as a solution to the unmet need in mCRPC.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}